Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02145364 · ClinicalTrials.gov registry record · NA
Ultherapy® for the Treatment of Acne Scars
A NA study, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02145364 is a NA study that has completed, run by Ulthera. The registered enrollment target is 20 participants.
The verdict
NCT02145364, a NA study, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a prospective, multi-site trial to be conducted at 2 clinical sites. Up to 20 subjects will receive study treatments. Following study treatments, follow-up visits will occur at 60, 90 and 180 days from each subject's last study treatment.
Interventions
- DEVICE Ultherapy® treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02145364
The ClinicalTrials.gov registry entry for NCT02145364 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultherapy® treatment is the first listed.
NCT02145364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02145364 about?
NCT02145364 is a clinical study titled "Ultherapy® for the Treatment of Acne Scars". This is a prospective, multi-site trial to be conducted at 2 clinical sites. Up to 20 subjects will receive study treatments. Following study treatments, follow-up visits will occur at 60, 90 and 180 days from each subject's last study treatment.
What is the current status of trial NCT02145364?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2014-05. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02145364?
The interventions under investigation include: Ultherapy® treatment (DEVICE).
Who is sponsoring clinical trial NCT02145364?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.